Shenrui Bai

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center

发表论文 2 篇

代表论文

• Single-cell profiling of natural killer/T-cell lymphoma reveals stratified immune features and potential therapeutic implications (2026 · Nature Communications)
• Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial (2026 · Nature Communications)